How many SEC Form 4 insider filings does GPCR have?

Structure Therapeutics Inc. (GPCR) has 17 SEC Form 4 filings (20 transaction rows) in the rolling 365-day window, disclosed by 0 distinct insiders. Most recent filing: Aug 7, 2026.

When was the most recent SEC Form 4 filing for GPCR?

The most recent Form 4 filing for GPCR on Tracefour is dated Aug 7, 2026.

GPCR

Name: GPCR Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: GPCR, insider trading, SEC Form 4, insider transactions

Structure Therapeutics Inc.

Structure Therapeutics Inc. (GPCR) has 17 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 0 distinct insiders. Most recent filing: Aug 7, 2026.

Industry:Biotechnology
CEO:Raymond C. Stevens
Employees:163
HQ:South San Francisco, CA, US
IPO:2023-02-03

No open-market insider trades for GPCR (Structure Therapeutics Inc.) in the last 365 days.

Why this page may be quiet. Tracefour displays Form 4 open-market purchases (P) and sales (S): the two transaction codes that signal directional conviction. Restricted stock grants, option exercises, gifts, and tax-withholding sales are filed but intentionally not shown: they're disclosure mechanics, not buy/sell decisions.

Many large-cap executives trade through pre-scheduled 10b5-1 plans set months in advance and batch-disclosed each quarter, so the latest filing on EDGAR for a mega-cap can be weeks old without any insider actually choosing to trade in that window.

See all Form 4 filings on SEC EDGAR ↗

Related companies

Structure Therapeutics Inc. is in the Healthcare sector.